Snap-8 – 10mg

SNAP-8 is a synthetic eight-amino-acid peptide with the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂. It is commonly identified by the INCI name Acetyl Octapeptide-3 and is structurally related to Acetyl Hexapeptide-8 (Argireline). The peptide was designed as a biomimetic fragment of SNAP-25, a component of the SNARE protein complex involved in vesicle fusion and neurotransmitter release. Research interest in SNAP-8 centers on its proposed interaction with the SNARE-assembly process and its potential relevance to cosmetic peptide and cellular-signaling studies. The 10 mg presentation is intended for qualified research environments conducting controlled investigations into peptide structure, SNARE-related pathways, cellular signaling, cosmetic peptide mechanisms, and related laboratory models.

Key Features

10 mg research-grade SNAP-8 Synthetic octapeptide Acetyl Octapeptide-3 Ac-EEMQRRAD-NH₂ sequence Biomimetic fragment related to SNAP-25 Relevant to SNARE-complex research Suitable for cosmetic peptide and cellular-signaling studies Intended for controlled laboratory research Appropriate for peptide characterization and analytical workflows Batch-level analytical documentation may be provided for applicable lots Research Focus SNAP-8 is primarily studied within cosmetic peptide and cellular-signaling research, particularly because of its structural relationship to the N-terminal region of SNAP-25. Its proposed mechanism involves competitive interaction with components involved in SNARE-complex assembly. The independent scientific evidence specifically evaluating SNAP-8 remains limited compared with better-characterized peptide research compounds. Therefore, claims regarding cosmetic efficacy should be presented conservatively and should not be represented as established clinical outcomes.

Important Notice

This product is supplied strictly for research and laboratory use. It is not intended for human or veterinary use, injection, self-administration, consumption, diagnosis, treatment, or prevention of disease. SNAP-8 should be handled only by appropriately qualified personnel in accordance with applicable laboratory protocols, analytical requirements, and regulations.